These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567 [TBL] [Abstract][Full Text] [Related]
9. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [ Bajorat R; Kurth J; Stenzel J; Vollmar B; Krause BJ; Reuter DA; Schuerholz T; Bergt S Mol Imaging Biol; 2022 Jun; 24(3):466-478. PubMed ID: 34779968 [TBL] [Abstract][Full Text] [Related]
10. Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. Capitanio S; Bongioanni F; Piccardo A; Campus C; Gonella R; Tixi L; Naseri M; Pennone M; Altrinetti V; Buschiazzo A; Bossert I; Fiz F; Bruno A; DeCensi A; Sambuceti G; Morbelli S World J Radiol; 2016 Feb; 8(2):200-9. PubMed ID: 26981229 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography/computed tomography using 2-deoxy-2-fluoro-18-fluoro-D-glucose peri-tumoral halo uptake layer method outperforms magnetic resonance imaging and ultrasound methods in tumor size measurement of breast cancer. Wu Y; Lu Y; Xu C; Lin B Oncol Lett; 2020 Jun; 19(6):3881-3888. PubMed ID: 32391098 [TBL] [Abstract][Full Text] [Related]
12. Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657 [TBL] [Abstract][Full Text] [Related]
13. [ Sollini M; Trenti N; Malagoli E; Catalano M; Di Mento L; Kirienko A; Berlusconi M; Chiti A; Antunovic L Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1605-1615. PubMed ID: 31044264 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET. Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565 [TBL] [Abstract][Full Text] [Related]
15. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC). Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718 [TBL] [Abstract][Full Text] [Related]